Records 1 - 6
| Protective role of +294 T/C (rs2016520) polymorphism of PPARD in Mexican patients with colorectal cancer.
Genetics and molecular research : GMR 2017 Jan 16 (1): .
Rosales-Reynoso M A, Wence-Chavez L I, Arredondo-Valdez A R, Dumois-Petersen S, Barros-Núñez P, Gallegos-Arreola M P, Flores-Martínez S E, Sánchez-Corona
| Association of functional genetic variants in PPARd encoding peroxisome proliferator-activated receptor delta with ischemic stroke in Chinese Uyghur population.
Journal of the neurological sciences 2015 Aug .
Tong Yeqing, Zhan Faxian, Cai Li, Han ShengHong, Guan Xuhuan, Lin Liangqiang, Li Xiaoxia, Hou Shuangyi, Lu Qing, Liu Jia
| Positive association between PPARD rs2016520 polymorphism and coronary heart disease in a Han Chinese population.
Genetics and molecular research : GMR 2015 14 (2): 6350-9.
Ye H D, Li Y R, Hong Q X, Zhou A N, Zhao Q L, Xu L M, Xu M Q, Xu X T, Tang L L, Dai D J, Jiang D J, Huang Y, Wang D W, Duan S
| Gene-gene interaction between PPARd and PPAR? is associated with abdominal obesity in a Chinese population.
Journal of genetics and genomics = Yi chuan xue bao 2012 Dec 39 (12): 625-31.
Ding Yi, Guo Zhi-Rong, Wu Ming, Chen Qiu, Yu Hao, Luo Wen-S
| Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population.
Heart and vessels 2010 May 25 (3): 229-36.
Nikitin Alexey G, Chistiakov Dimitry A, Minushkina Larissa O, Zateyshchikov Dmitry A, Nosikov Valery
| Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study.
Pharmacogenetics 2004 Jan 14 (1): 61-71.
Chen Suetnee, Tsybouleva Natalia, Ballantyne Christie M, Gotto Antonio M, Marian A